Want to see JP:3151 full AI Analyst Report?
3151 Stock Chart & Stats
¥1370.00
-¥1.00(-0.08%)
At close: 4:00 PM EST
¥1370.00
-¥1.00(-0.08%)
Day’s Range― - ―
52-Week Range¥1,226.00 - ¥1,678.00
Previous CloseN/A
Volume69.00K
Average Volume (3M)121.33K
Market Cap
¥74.74B
Enterprise Value¥57.70B
Total Cash (Recent Filing)¥22.95B
Total Debt (Recent Filing)¥6.78B
Price to Earnings (P/E)10.9
Beta0.48
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.21%
Share Statistics
EPS (TTM)152.32
Shares Outstanding51,902,977
10 Day Avg. Volume69,970
30 Day Avg. Volume121,326
Financial Highlights & Ratios
PEG Ratio4.38
Price to Book (P/B)0.60
Price to Sales (P/S)0.12
P/FCF Ratio63.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow and declining leverage with rising equity provides durable financial flexibility. A stronger capital base reduces refinancing and solvency risk, supports dividend distributions and strategic optionality (M&A or working-capital support), and cushions the company through sector cycles.
Revenue Acceleration And Higher Net IncomeA sharp revenue uptick coupled with materially higher net income indicates meaningful top-line momentum or successful execution. Sustained revenue expansion broadens the earnings base and can enable scale benefits, improving long-term competitiveness if margins and cash conversion follow.
Consistent Operating ProfitabilityContinuous operating profits reflect a resilient distribution model able to cover fixed costs and generate operating earnings across cycles. Even with thin margins, persistent operating profitability lowers bankruptcy risk, supports ongoing operations and distributions, and underpins medium-term stability.
Bears Say
Volatile Cash GenerationLarge swings in operating and free cash flow indicate inconsistent conversion of earnings to cash, likely driven by working-capital timing in distribution. This undermines the firm's ability to reliably fund capex, dividends or debt service and raises execution and liquidity risk over the medium term.
Structurally Thin Margins And Recent EBIT DeclinePersistently slim margins constrain the firm's ability to absorb cost shocks or translate revenue growth into durable profits. The decline in EBIT despite revenue acceleration signals margin pressure or integration/scale inefficiencies, making profitability sensitive to cost or pricing changes long-term.
Moderate Returns On EquityRelatively low ROE indicates limited capital efficiency: equity growth has not translated into strong returns. Over the medium term this constrains shareholder value creation and means growth may require additional capital or leverage to materially lift returns, raising strategic pressure on management.
Vital KSK Holdings, Inc. News
3151 FAQ
What was Vital KSK Holdings, Inc.’s price range in the past 12 months?
Vital KSK Holdings, Inc. lowest stock price was ¥1226.00 and its highest was ¥1678.00 in the past 12 months.
What is Vital KSK Holdings, Inc.’s market cap?
Vital KSK Holdings, Inc.’s market cap is ¥74.74B.
When is Vital KSK Holdings, Inc.’s upcoming earnings report date?
Vital KSK Holdings, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 12 days.
How were Vital KSK Holdings, Inc.’s earnings last quarter?
Vital KSK Holdings, Inc. released its earnings results on May 14, 2026. The company reported ¥30.44 earnings per share for the quarter, beating the consensus estimate of N/A by ¥30.44.
Is Vital KSK Holdings, Inc. overvalued?
According to Wall Street analysts Vital KSK Holdings, Inc.’s price is currently Overvalued.
Does Vital KSK Holdings, Inc. pay dividends?
Vital KSK Holdings, Inc. pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 4.21%. See more information on Vital KSK Holdings, Inc. dividends here
What is Vital KSK Holdings, Inc.’s EPS estimate?
Vital KSK Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vital KSK Holdings, Inc. have?
Vital KSK Holdings, Inc. has 51,902,977 shares outstanding.
What happened to Vital KSK Holdings, Inc.’s price movement after its last earnings report?
Vital KSK Holdings, Inc. reported an EPS of ¥30.44 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.962%.
Which hedge fund is a major shareholder of Vital KSK Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:3151
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vital KSK Holdings, Inc.
Vital KSK Holdings, Inc. is a Japanese entity primarily involved in the wholesale distribution of pharmaceutical products. Its diverse wholesale operations also cover veterinary medications, agricultural chemicals and supplies, and various types of medical and nursing care equipment. Beyond its core distribution activities, the company manages a range of services including operating pharmacies, providing nursing care, transportation, insurance agency services, real estate management, and parking facilities. It also runs a mail-order business focused on health-related products and offers pharmacy dispensing services. Furthermore, Vital KSK Holdings provides medical management consulting and manufactures over-the-counter (OTC) drugs. The company was established in 2009 and maintains its headquarters in Tokyo, Japan.
Technical Analysis
OLBA HEALTHCARE HOLDINGS, Inc.
―
Ohki Health Care Holdings, Inc.
―
Charm Care Corporation
―
Amvis Holdings.Inc.
―
YAMASHITA HEALTH CARE HOLDINGS, INC.
―